Light-chain amyloid myopathy isolated to skeletal muscles: A case report

Toshihiro Matsukawa; Katsuki Eguchi; Ichizo Nishino; Kohei Okada; Kazuo Oshimi; Takuto Miyagishima

doi:10.1002/ccr3.3310

Light-chain amyloid myopathy isolated to skeletal muscles: A case report

Clin Case Rep. 2020 Sep 8;8(12):2869-2873. doi: 10.1002/ccr3.3310. eCollection 2020 Dec.

Authors

Toshihiro Matsukawa¹, Katsuki Eguchi², Ichizo Nishino³, Kohei Okada¹, Kazuo Oshimi¹, Takuto Miyagishima¹

Affiliations

¹ Department of Internal Medicine/Hematology Kushiro Rosai Hospital Kushiro Japan.
² Department of Neurology Kushiro Rosai Hospital Kushiro Japan.
³ Department of Neuromuscular Research National Institute of Neuroscience Tokyo Japan.

Abstract

Isolated amyloidosis, especially of amyloid light-chain type, is an infrequent disease. Systemic chemotherapy for light-chain amyloidosis isolated to skeletal muscles plays a key role to reduce clonal plasma cells producing aberrant immunoglobulin.

Keywords: amyloidosis; isolated amyloid myopathy; light‐chain.

Publication types

Case Reports